World Health Organization Sounds Alert Over Acute Shortage of Weight-Loss Medications

Under a tenth of patients eligible to benefit from weight-loss injections like Wegovy are able to get them, warns the World Health Organization as it publishes its inaugural advice on the medications.

With in excess of 1,000,000,000 individuals worldwide now living with obesity, it is advocating for broader and more equitable availability to this class of drugs.

According to estimates, over two billion could be living with obesity by 2030 without intervention.

"The latest guidance recognises that excess weight is a lifelong illness that can be treated with thorough and ongoing support," said WHO director-general Tedros Adhanom Ghebreyesus.

High costs, limited production capacity, and distribution challenges are major obstacles to broad availability to the injections that can assist patients in reducing significant weight, notes the organization.

GLP-1 Therapy Scarcity

Despite the present most optimistic case, the production of these medications might only reach about 100 million people – fewer than 10% of the global need, per the health organization.

The recommendation encourages nations and manufacturers to expand access, by measures such as voluntary licensing.

Exclusive production rights on a key compound – the primary component of a leading brand – is scheduled to end in a number of nations in 2026.

The Way Obesity Jabs Operate

GLP-1 drugs mimick a body's own hormone to delay gastric emptying, suppress the appetite and increase the sense of being full so users reduce food intake.

Individuals typically see weight reduction after several weeks of beginning the regular doses.

Evidence indicates people may put most of the weight back on a year later of halting the drug, because their typical food cravings resume.

To be overweight or obese elevates your likelihood for contracting health problems, such as type 2 diabetes, heart disease, brain attack, and some malignancies.

Excess weight concerns individuals in countries worldwide and was responsible for over three and a half million fatalities worldwide in 2024, per the WHO.